AMNEAL Pharmaceuticals announced the approval of their [Substance] abbreviated new drug application, a move that is projected to drive significant cos...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
On December 27, 2024, the FDA approved **E.R. Squibb & Sons, L.L.C.**’s OPDIVO QVANTIG (nivolumab and hyaluronidase-nvhy), a novel subcutaneous formul...
# FDA Approves Generic Drug Application for Aurobindo Pharma Aurobindo Pharma Ltd. received FDA approval for ANDA215971 on December 26, 2024, expandi...
On December 19, 2024, Ionis Pharmaceuticals received FDA approval for TRYNGOLZA (olezarsen sodium), a novel subcutaneous product addressing an unmet n...
Grex, Inc. (GRANULES) received approval on December 16, 2024, for its Abbreviated New Drug Application (ANDA219258), unleashing significant pricing pr...
Checkpoint Therapeutics Inc. announced FDA approval of its drug following the Dec. 13 notice, a development the company is positioning as a pivotal mo...
The FDA’s approval of Zenocutuzumab (Bizengri) on December 4 grants Merus US, Inc. commercial rights to a first-in-class therapy for NRG1 fusion-posit...
Biocon Biologics Inc. announced the FDA approval of YESINTEK (ustekinumab) for the treatment of moderate-to-severe plaque psoriasis, a strategic expan...
Jazz Pharmaceuticals announced on Friday the FDA approval of ZIIHERA (zanidatamab) for heavily pretreated gastroesophageal junction and HER2-positive ...
Amneal Pharmaceuticals LLC has received FDA approval for its ANDA for exenatide injection, setting the stage for increased market competition in the d...
Wuxi Fortune Pharmaceutical has secured FDA approval for its generic Mycophenolate Mofetil (ANDA 214079), signals an escalation in its U.S. market pre...
On November 7, 2024, Azurity Pharmaceuticals received FDA approval for Danziten (nilotinib), expanding access to this oral therapy amid a competitive ...
Camber Pharmaceuticals announced today that the FDA has approved ANDA 207022 for Mycophenolate Mofetil, marking a new entry into the market for the im...
FDA granted approval today to Camber Pharmaceuticals for Mycophenolate Mofetil oral tablets, expanding its 2 mg strength to a 500 mg dosage in respons...
# FDA Approves UBI Pharma's Generic Leuprolide Acetate Injection The FDA has approved UBI Pharma Inc.'s abbreviated new drug application (ANDA) for l...
# FDA Approves AbbVie's VYALEV for Parkinson's Disease Treatment AbbVie Inc. received FDA approval for VYALEV (foscarbidopa/foslevodopa) subcutaneous...
# FDA Approves Pfizer's HYMPAVZI for Hemophilia A Treatment Pfizer has received FDA approval for HYMPAVZI (marstacimab-hncq), a subcutaneous therapy ...
# FDA Approves Genentech's ITOVEBI (inavolisib) for PIK3CA-Mutant Breast Cancer Genentech announced FDA approval of ITOVEBI (inavolisib), an oral PI3...
# FDA Approves Amneal Pharmaceuticals' Pyridostigmine Bromide Oral Formulation Amneal Pharmaceuticals LLC received FDA approval for its oral pyridost...
# FDA Approves Generic Pomalidomide; Camber Pharmaceuticals Entry Expected to Intensify Competition Camber Pharmaceuticals, Inc. received FDA approva...